Clinical

Our xTAG® and MultiCode™-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
 
Read More

Research & Applied Markets

Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
 
Read More

Become a Partner

Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
 
Learn More

Luminex® Blog

Luminex Licensed Technologies Partner Spotlight: Bio-Techne

Helping users make the switch from single-analyte ELISAs to multiplexing

For scientists who are new to multiplexing, Bio-Techne is a great place to start. This well-known ELISA kit manufacturer makes it easy for users to make the transition from manual, single-analyte ELISAs to robust multiplex testing with xMAP® Technology. In this partner spotlight, we spoke with Liz Cremer, immunoassay instrument specialist at Bio-Techne, to learn more about how Bio-Techne uses xMAP to solve customer challenges.

Continue Reading >

xMAP® Technology Overview

 
Luminex xMAP® Technology Overview

 

xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.

Watch more videos >

Luminex on Twitter


Planar protein array production can be painful and not always reproducible. Luckily, Luminex has saved the day for… https://t.co/E62vvoKE0R
h J R
"A lot of customers come to us for a very simple reason: they need a lot of answers out of a very small amount of s… https://t.co/lEZ38Q8Efo
h J R
Before joining Luminex, Liam Parrent worked in insurance, employee benefits, and HR. How have those experiences sha… https://t.co/KhcvIzBeBM
h J R

Latest News

November 5
Luminex Corporation Reports Third Quarter 2018 Financial Results

October 18
Luminex Corporation to Acquire MilliporeSigma’s Flow Cytometry Portfolio

October 15
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2018

September 11
Luminex Corporation Declares Third Quarter Cash Dividend

September 6
Luminex Corporation to Present at the Morgan Stanley 16th Annual Global Healthcare Conference

Events

xMAP® Connect Amsterdam
6-7 November
Amsterdam, Netherlands